Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781] November 7, 2026 Gastrointestinal Cancer
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery November 7, 2026 Gastrointestinal Cancer
Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Cancer November 7, 2026 Gastrointestinal Cancer
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer November 7, 2026 Gastrointestinal Cancer
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors November 7, 2026 Gastrointestinal Cancer
Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer November 7, 2026 Gastrointestinal Cancer
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer November 7, 2026 Gastrointestinal Cancer
Panitumumab, Docetaxel, Cisplatin, Radiation Therapy, and Surgery in Treating Patients With Newly Diagnosed, Locally Advanced Esophageal Cancer or Cancer of the Gastroesophageal Junction November 7, 2026 Gastrointestinal Cancer
Combination Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer November 7, 2026 Gastrointestinal Cancer
Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer November 7, 2026 Gastrointestinal Cancer